https://www.novumpr.nl/2018/03/23/ipsen-receives-positive-chmp-opinion-for-cabometyx-cabozantinib-for-the-first-line-treatment-of-adults-with-intermediate-or-poor-risk-advanced-renal-cell-carcinoma-2/?utm_source=rss&utm_medium=rss&utm_campaign=ipsen-receives-positive-chmp-opinion-for-cabometyx-cabozantinib-for-the-first-line-treatment-of-adults-with-intermediate-or-poor-risk-advanced-renal-cell-carcinoma-2 NovumPR press releases Fri, 23 Mar 2018 08:07:00 +0000 hourly 1 https://wordpress.org/?v=6.8.3